ESOPJun 10, 2026, 04:13 PM
Ascendis Pharma Grants 27,030 Employee Warrants at $213.23 Exercise Price
AI Summary
Ascendis Pharma A/S announced the grant of an aggregate of 27,030 warrants to certain employees on June 9, 2026. Each warrant allows the holder to subscribe for one ordinary share at an exercise price of US $213.23, which was the closing price on the grant date. The warrants have a vesting schedule, with 25% vesting after one year and the remainder vesting monthly thereafter, contingent on continued service. Following this grant, 1,553,563 shares remain available for future warrant grants under the company's Articles of Association.
Key Highlights
- Ascendis Pharma granted 27,030 warrants to certain employees.
- Each warrant confers the right to subscribe for one ordinary share.
- The exercise price for each warrant is US $213.23 per share.
- 25% of the warrants vest on the one-year anniversary of the grant date.
- The remaining 75% vest at 1/36th per month after one year, subject to continued service.
- 1,553,563 shares remain available for future warrant grants.
Price Impact
More from ASND